Adverse Impacts of Severe ASCVD: Is PCSK9 Inhibition the Key to Improve Patient Outcomes?
Format: Webcourse
Credit(s): 1.00 (60 min)
Release Date: Dec 18, 2017
Expiration Date: Dec 18, 2018
Credit Type(s):
- CME / AMA PRA Category 1 Credit™
- MOC / ABIM MOC Part 2 Credit
PROGRAM OVERVIEW
RELATED COURSES
22
Mar
Mar
